Maureen E. Murphy

Maureen E. Murphy

Auto-generated profile, based on publicly available information

Maureen E. Murphy

Program in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, Pennsylvania 19104, USA

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2003 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
PDPatrick Dumont
Patrick Dumont
JLJ. I-Ju Leu
J. I-Ju Leu
APAnthony C. Della Pietra
Anthony C. Della Pietra
DGDonna L. George
Donna L. George
MMMaureen Murphy
Maureen Murphy

26 December 2004 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
TLTongxiang Lin
Tongxiang Lin
CCConnie Chao
Connie Chao
SSShin'Ichi Saito
Shin'Ichi Saito
SMSharlyn J. Mazur
Sharlyn J. Mazur
MMMaureen E. Murphy
Maureen E. Murphy
YXYang Xu
Yang Xu

1 February 2002 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
WHWilliam H. Hoffman
William H. Hoffman
SBSiham Biade
Siham Biade
JZJack T. Zilfou
Jack T. Zilfou
JCJiandong Chen
Jiandong Chen
MMMaureen Murphy
Maureen Murphy
Survivin is a member of the inhibitor of apoptosis family. This apoptosis inhibitor also has an evolutionarily conserved role as a mitotic spindle checkpoint protein. Previous studies on p53-repressed genes have implicated several genes involved in the G2/M transition of the cell cycle as targets of negative regulation by p53. However, few targets of p53 repression that are anti-apoptotic have been identified. This study identifies the anti-apoptotic survivin gene as a p53-repressed gene. Notably, Survivin repression by p53 is shown to be distinct from p53-dependent growth arrest. Chromatin immunoprecipitations indicate that p53 binds the survivinpromoter in vivo; immunobinding studies indicate that this site overlaps with a binding site for E2F transcription factors and is subtly distinct from a canonical p53-transactivating element. Thesurvivin-binding site contains a 3-nucleotide spacer between the two decamer “half-sites” of the p53 consensus element; deletion of this spacer is sufficient to convert thesurvivin site into a transactivating element. Finally, we show that overexpression of Survivin in cells sensitive to p53-dependent cell death markedly inhibits apoptosis induced by ultraviolet light. The identification ofsurvivin as a p53 repressed gene should aid in the elucidation of the contribution of transcriptional repression to p53-dependent apoptosis.

4 April 2013 in Carcinogenesis
Verified
Journal Article
Open access
PDF file
MMMaureen E. Murphy
Maureen E. Murphy
The HSP70 family of heat shock proteins consists of molecular chaperones of approximately 70kDa in size that serve critical roles in protein homeostasis. These adenosine triphosphatases unfold misfolded or denatured proteins and can keep these proteins in an unfolded, folding-competent state. They also protect nascently translating proteins, promote the cellular or organellar transport of proteins, reduce proteotoxic protein aggregates and serve general housekeeping roles in maintaining protein homeostasis. The HSP70 family is the most conserved in evolution, and all eukaryotes contain multiple members. Some members of this family serve specific organellar- or tissue-specific functions; however, in many cases, these members can function redundantly. Overall, the HSP70 family of proteins can be thought of as a potent buffering system for cellular stress, either from extrinsic (physiological, viral and environmental) or intrinsic (replicative or oncogenic) stimuli. As such, this family serves a critical survival function in the cell. Not surprisingly, cancer cells rely heavily on this buffering system for survival. The overwhelming majority of human tumors overexpress HSP70 family members, and expression of these proteins is typically a marker for poor prognosis. With the proof of principle that inhibitors of the HSP90 chaperone have emerged as important anticancer agents, intense focus has now been placed on the potential for HSP70 inhibitors to assume a role as a significant chemotherapeutic avenue. In this review, the history, regulation, mechanism of action and role in cancer of the HSP70 family are reviewed. Additionally, the promise of pharmacologically targeting this protein for cancer therapy is addressed.

15 April 2000 in Genes & Development
Verified
Journal Article
Open access
PDF file
RZRenbin Zhao
Renbin Zhao
KGKurt Gish
Kurt Gish
MMMaureen Murphy
Maureen Murphy
YYYuxin Yin
Yuxin Yin
DNDaniel Notterman
Daniel Notterman
ALArnold J. Levine
Arnold J. Levine
Oligonucleotide microarrays were employed to quantitate mRNA levels from a large number of genes regulated by the p53 transcription factor. Responses to DNA damage and to zinc-inducible p53 were compared for their transcription patterns in cell culture. A cluster analysis of these data demonstrates that genes induced by γ radiation, UV radiation, and the zinc-induced p53 form distinct sets and subsets with a few genes in common to all these treatments. Cell type- or cell line-specific p53 responses were detected. When p53 proteins were induced with zinc, the kinetics of induction or repression of mRNAs from p53-responsive genes fell into eight distinct classes, five different kinetics of induction, and three different kinetics of repression. In addition, low levels of p53 in a cell induced or repressed only a subset of genes observed at higher p53 levels. The results of this study demonstrate that the nature of the p53 response in diverse mRNA species depends on the levels of p53 protein in a cell, the type of inducing agent or event, and the cell type employed. Of 6000 genes examined for p53 regulatory responses, 107 induced and 54 repressed genes fell into categories of apoptosis and growth arrest, cytoskeletal functions, growth factors and their inhibitors, extracellular matrix, and adhesion genes.

1 October 2009 in Molecular Cell
Verified
Journal Article
Closed access
JLJ. I-Ju Leu
J. I-Ju Leu
JPJulia Pimkina
Julia Pimkina
AFAmanda Frank
Amanda Frank
MMMaureen E. Murphy
Maureen E. Murphy
DGDonna L. George
Donna L. George